Elekta

During the event, we will provide an in-depth look at our innovative products and solutions, as well as an update on Elekta's progress in key areas. This is an excellent opportunity to gain insights into Elekta's strategic direction and future growth prospects.

To attend (online or in person) and for more information, please register through the following link no later than June 2, 2025: https://events.elekta.com/Investor-Update. A recording of the Investor Update will be published on Elekta’s website after the event.

# # #

For further information, please contact:
Peter Nyquist, Head of Investor Relations
Tel: +46 70 575 2906, e-mail: peter.nyquist@elekta.com
Time zone: CEST (Central European Summer Time)

About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,500 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com.